Symonds Erin L, Cock Charles, Meng Rosie, Cole Stephen R, Fraser Robert J L, Young Graeme P
Bowel Health Service.
Flinders Centre for Innovation in Cancer.
Eur J Cancer Prev. 2018 Sep;27(5):425-432. doi: 10.1097/CEJ.0000000000000352.
Participation rates in colorectal cancer (CRC) screening programmes using faecal occult blood tests (FOBTs) are low. Nonparticipation is commonly attributed to psychosocial factors, but some medical conditions also prevent screening. These barriers might be partially overcome if a blood test for CRC screening was available. This study determined whether people who had always declined screening by FOBT would participate if offered a blood test. An audit of registrants within a personalized CRC screening programme was undertaken to determine the reasons for regular nonparticipation in FOBT. Consistent nonparticipants (n=240) were randomly selected and invited for CRC screening with a blood test. Demographic characteristics and the reasons for prior FOBT nonparticipation were collected by means of a questionnaire. Nonparticipation in the screening programme could be classified as either behavioural (8.6%), with consistent noncompliance, or due to medical contraindications (8.5%), which included chronic rectal bleeding, being deemed unsuitable by a health professional, and needing personal assistance. Blood test uptake was 25%, with participation in the medical contraindications group greater than that in the behavioural group (43 vs. 12%, P<0.001). Reported behavioural reasons for nonparticipation in faecal immunochemical test included procrastination and dislike of the test, but these were not associated with blood test uptake (P>0.05). There is a subgroup of the community who have medical reasons for nonparticipation in CRC screening with FOBT but will participate if offered a blood test. The option of a blood test does not, however, improve uptake in those who admit to behavioural reasons for noncompliance with screening.
使用粪便潜血试验(FOBT)的结直肠癌(CRC)筛查项目的参与率较低。不参与通常归因于社会心理因素,但一些医疗状况也会妨碍筛查。如果有用于CRC筛查的血液检测,这些障碍可能会部分得到克服。本研究确定了那些一直拒绝FOBT筛查的人在提供血液检测时是否会参与。对个性化CRC筛查项目中的登记人员进行了审核,以确定定期不参与FOBT的原因。随机选择持续不参与者(n = 240),并邀请他们进行CRC血液检测筛查。通过问卷调查收集人口统计学特征和先前不参与FOBT的原因。筛查项目的不参与可分为行为性(8.6%),即持续不遵守,或由于医疗禁忌(8.5%),包括慢性直肠出血、被健康专业人员认为不适合以及需要个人协助。血液检测的接受率为25%,医疗禁忌组的参与率高于行为组(43%对12%,P<0.001)。报告的不参与粪便免疫化学检测的行为原因包括拖延和不喜欢该检测,但这些与血液检测的接受率无关(P>0.05)。社区中有一个亚组人群因医疗原因不参与FOBT的CRC筛查,但如果提供血液检测则会参与。然而,血液检测选项并不能提高那些承认因行为原因不遵守筛查的人的接受率。